From Start-Up to Scale-Up
NAVIGATING THE PATH TO DEPLOYMENT AT SCALE
BeyondBio SCALE helps connect healthcare needs to solutions at scale and at speed. The unique 9-month program is dedicated to helping you navigate the challenging journey from start-up to scale-up. Selected, evidence-based startups get a seat at the table with an extraordinary, interdisciplinary team of global partners: Accenture, AWS, and Clalit Innovation, as well as AstraZeneca. Each sharing world-class insights, expertise, resources, and connections equipping your startup to accelerate deployment at scale.
BeyondBio SCALE is part of AstraZeneca’s BeyondBio Innovation Hub in Israel, in partnership with AstraZeneca’s A.Catalyst global innovation network. Our vision at BeyondBio is to dramatically improve patient care and healthcare systems around the world, by advancing cutting-edge science, technology, and innovation out of Israel.
1. READY TO SCALE? LET'S TALK
You’ve built a great, evidence-backed startup, with potential to make a real impact in the healthcare space. Now, BeyondBio SCALE can help you grow successfully and efficiently. To ensure mutual compatibility, we’ll first assess your solution and its ability to address key challenges in the following clinical focus areas:
- Respiratory and Immunology
- Cardiovascular, Renal & Metabolic Diseases
- Vaccines and Infections
The most relevant and promising solutions will be accepted, and each participating company will receive support tailored to its own unique needs.
2. IDENTIFY A SCALABLE USE CASE WITH ECOSYSTEM PLAYERS
Welcome to the BeyondBio SCALE program!
Together with our program partners – AstraZeneca, Accenture, AWS and Clalit Health Services, we’ll identify a specific scalable use case for your solution.
We then engage “champions” from our global organizations, matching you with relevant experts, resources and senior business leaders who can help propel your solution onto the world stage.
3. VALIDATE YOUR SOLUTION TOWARDS IMPLEMENTATION
At this stage we’ll help you create a detailed plan for scaling. Based on the use case, your solution will be analyzed from different angles including the commercial, clinical, regulatory, technology and business perspectives. We’ll stress-test, revise and iterate together, utilizing core competencies of the program partners as needed.
Together, we’ll set a series of practical discussions with relevant stakeholders, aspiring to achieve maximum readiness for growth.
4. START SCALING
Now you’re ready to deploy your solution, implementing the right model and metrics for your use case. The pathways to deployment could range from a pilot abroad, to a validation study, a collaboration agreement, a product launch at scale, and more.
BeyondBio is deeply committed to turbocharging innovation – and that means this process doesn’t end after the 9-month program. The foundations and connections we build together will continue to evolve into the future.
So, are you ready to SCALE?
STARTUPS ON THEIR JOURNEY TO SCALE
Early Cancer Detection Platform
Using cutting-edge scientific breakthroughs, growing genomic and clinical databases, sophisticated signal processing and AI, C2i enables high precision personalized medicine, reduced cancer treatment costs, and accelerated drug development. In a collaboration with AstraZeneca’s global R&D teams, C2i’s tumor burden monitoring technology was successfully validated and determined to be suitable for further collaboration which is currently being scoped.
Digital Pathology AI Tool
Ibex offers the most widely-deployed artificial intelligence platform in pathology, helping physicians streamline diagnostic workflows. The company signed and is currently operationalizing, a validation agreement with AstraZeneca for a digital pathology tool.
Voice-based Heart Failure management
Using a patient’s speech, sampled via a mobile device, Cordio HearO™ senses fluid accumulation related to congestive heart failure and alerts healthcare providers and physicians to drive improved care. Cordio is working with AstraZeneca Spain to launch the company’s voice-based heart failure management solution in two leading European hospitals. In addition, a dialogue was initiated with an AWS speech-analysis team.
Asthma Digital Therapeutics Platform
Together with Astra Zeneca, docdok.health has launched a clinical study in Israel and Switzerland that will use their platform to develop next-generation asthma management algorithms. docdok’s digital therapeutics platform drives value-based healthcare by capturing, understanding, and enhancing real-world patient outcomes using digital data.
For medical inquiries about our products, please use the following email: firstname.lastname@example.org
For other questions, please call 073-222-6099.
Lines are open from Sunday-Thursday, 8am-5pm (excluding holidays).